Derivative Financial Instruments (Tables)

9 Months Ended

Sep. 28, 2025

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Cash Flow Hedging Instruments

The notional amounts and fair values of the Company's foreign currency forward contracts designated as cash flow hedging instruments were as follows:

	September 28, 2025				September 29, 2024				December 29, 2024
Hedged transaction	Notional Amount		Fair Value		Notional Amount		Fair Value		Notional Amount		Fair Value
Inventory purchases	$	208.7	$	(9.9)	$	164.7	$	1.3	$	131.5	$	8.0
Sales	106.7		2.4		104.6		(3.2)		86.0		(1.4)
Other	51.8		(0.7)		26.4		1.5		22.8		0.9
Total	$	367.2	$	(8.2)	$	295.7	$	(0.4)	$	240.3	$	7.5

Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location

The fair values of the Company's foreign currency forward contracts designated as cash flow hedges are recorded in the Consolidated Balance Sheets as follows:

	September 28, 2025		September 29, 2024		December 29, 2024
Prepaid expenses and other current assets
Unrealized gains	$	0.5	$	3.1	$	9.1
Unrealized losses	(0.2)		(0.2)		(1.1)
Net unrealized gains	$	0.3	$	2.9	$	8.0
Other assets
Unrealized gains	$	0.3	$	0.5	$	—
Unrealized losses	(0.2)		—		—
Net unrealized gains	$	0.1	$	0.5	$	—
Accrued liabilities
Unrealized gains	$	2.6	$	1.0	$	0.5
Unrealized losses	(8.7)		(4.0)		(1.0)
Net unrealized losses	$	(6.1)	$	(3.0)	$	(0.5)
Other liabilities
Unrealized gains	$	0.5	$	0.1	$	—
Unrealized losses	(3.0)		(1.0)		—
Net unrealized losses	$	(2.5)	$	(0.9)	$	—

Schedule of Derivative Instruments, Gain (Loss) in Statement of Operations

Net gains (losses) on cash flow hedging activities have been reclassified from other comprehensive earnings (loss) to net earnings (loss) as follows:

	Three Months Ended				Nine Months Ended
	September 28, 2025		September 29, 2024		September 28, 2025		September 29, 2024
Statements of Operations Classification
Cost of sales	$	(0.6)	$	(0.6)	$	1.2	$	(0.7)
Net revenues	0.4		0.8		0.3		1.4
Other	(0.3)		(0.3)		(0.3)		—
Net realized (losses) gains	$	(0.5)	$	(0.1)	$	1.2	$	0.7

Schedule of Fair Values of Undesignated Derivative Financial Instruments

The fair values of the Company's undesignated derivative financial instruments were recorded in the Consolidated Balance Sheets as follows:

	September 28, 2025		September 29, 2024		December 29, 2024
Prepaid expenses and other current assets
Unrealized gains	$	1.2	$	—	$	1.9
Unrealized losses	(0.6)		—		(0.2)
Net unrealized gains	$	0.6	$	—	$	1.7
Accrued liabilities
Unrealized gains	$	—	$	0.2	$	—
Unrealized losses	—		(2.2)		(1.2)
Net unrealized losses	$	—	$	(2.0)	$	(1.2)